With the rapid growth of our business, the demands of our customers for our N N N Trimethylethylenediamine, p Dimethylaminobenzaldehyde, epinephrine powder have increased, so the spirit of responsibility for our customers has been essential. We create the development space for employees' career needs and integrate personal development with enterprise development. We vigorously carry out the technological innovation work with new technology development as the main content, and strive to realize the upgrading of products and technology, and promote the leapfrog development of the enterprise. We prioritize the interests of customers to carry out business operations, achieving a 'win-win' for manufacturers, distributors and users. From design to research and development, the products strive to create a combination of practicality and artistry to meet the needs of modern commercial consumption.
Tetracaine hcl powder CAS 136-47-0 is mainly used in laboratory R&D process and chemical and pharmaceutical production process. It is a water-soluble local anesthetic with physical properties including melting point, solubility, thermal stability, photostability, density, and refractive index. These properties are related to purity, and the higher the purity, the more stable the physical properties. It is a compound with poor light stability and is easy to be photodegradation. Therefore, it is necessary to protect it from light exposure during storage. The density is 1.08 g/cm ^ 3 (25 ℃). In the liquid or gas state, this value may vary. The refractive index is 1.535 (20 ℃). Like the melting point, the refractive index is related to its purity, and high-purity It has a higher refractive index. Various chemical reactions such as carboxylation, alkylation, oxidation, chlorination, and reduction can be carried out in solution. The laboratory has accurately determined his chemical information, and the results are as follow:
|
Chemical Formula |
C15H25ClN2O2 |
|
Exact Mass |
35.98 |
|
Molecular Weight |
36.46 |
|
m/z |
204 (100.0%), 205 (11.9%), 206 (4.5%) |
|
Elemental Analysis |
C, 64.67; H, 5.92; N, 13.71; S, 15.69 |
Other information of chemical compound:
|
Morphological |
Solid or Viscous Liquid |
|
refractive index |
1.5200 ( estimate ) |
|
Melting point |
149 °C |
|
Boiling point |
403.5 °C |
|
Density |
1.1279 ( rough estimate) |
|
Storage conditions |
2-8 °C |
|
solubility alcohol |
solublesoluble 40 parts of solvent |
|
Acidity coefficient ( pKa ) |
8.39 ( at 25 °C ) |
|
Soluble in water |
50mg / ml |
|
|
|
Tetracaine hcl powder is an organic synthetic intermediate and pharmaceutical intermediate, which is mainly used in laboratory research and development process and chemical and pharmaceutical production process.
Photochemical reaction:
Tetracaine Hydrochloride is susceptible to the influence of light, and ultraviolet and blue purple light are particularly prone to its decomposition. The products of photochemical reactions can affect the efficacy of Tetracaine Hydrochloride. Tetracaine chloride, is a local anesthetic. Photochemical reaction refers to the excitation of photons by molecules in a solution or solid, triggering a chemical reaction. In the photochemical reaction of Tetracaine Hydrochloride molecules, after being excited by photons, spontaneous fracture reactions occur and harmful chemicals are released.
The photochemical reaction of Tetracaine Hydrochloride mainly consists of two parts:
Electron excitation and ultrafast chemical reaction.
Electronic excitation refers to the generation of excited state electrons after molecules absorb photons. The energy absorption of photons by molecules can increase the energy levels of electrons, making them more energetic and chemically reactive. After molecules absorb photons, processes such as spin flipping, resonance energy transfer, and electron transfer can occur, promoting electron excitation and chemical reactions. However, these excited state electrons are prone to fragmentation reaction, producing harmful ions and free radicals, causing serious cell damage.
Ultrafast chemical reaction
Ultrafast chemical reaction refers to the chemical reaction of excited state molecules in a very short time. Tetracaine hydrochloride molecules may undergo similar ultrafast chemical reactions, such as electron transfer, fluorescence resonance energy transfer, etc., after photoexcitation. These reactions can produce harmful substances and cause serious damage to cells. In addition, photochemical reactions may also trigger a series of other reactions, such as redox reactions, free radical chain reactions, etc.
In summary, in the photochemical reaction of tetracaine hcl powder molecules, the molecules excited by photons will undergo spontaneous fracture reactions and release harmful chemicals. These reactions have serious impacts on organisms, including cell damage, organ toxicity, etc. Therefore, when using Tetracaine Hydrochloride, it is necessary to avoid its exposure to light in order to reduce the occurrence of these reactions.
This drug may interact with other drugs during use, which may affect its efficacy or increase the risk of adverse reactions. The following is a summary of possible interactions with other drugs:
Other local anesthetics
When used in combination with procaine, lidocaine, etc., it may enhance the local anesthetic effect, but at the same time, it may also increase the risk of toxic reactions. Therefore, it is necessary to pay attention to adjusting the dosage during use to avoid excessive use.
Antiarrhythmic
Antiarrhythmic drugs such as amiodarone may affect cardiac conduction and increase the likelihood of arrhythmia when used in combination. Therefore, for patients who need to use both drugs simultaneously, close monitoring of electrocardiogram and other indicators should be carried out to ensure medication safety.
Muscle relaxants
Muscle relaxants such as vecuronium may enhance their muscle relaxation effect when used in combination, leading to adverse reactions such as respiratory depression. Therefore, special attention should be paid to the patient's respiratory condition during use to ensure unobstructed airway.
Sedative-hypnotics
When used in combination with sedatives such as diazepam and phenobarbital, it may enhance central inhibitory effects and increase the risk of drowsiness, coma, and other symptoms. Therefore, for patients who need to use both drugs simultaneously, their consciousness status should be closely monitored to avoid accidents.
Liver enzyme inhibitor
When used in combination with liver enzyme inhibitors such as cimetidine and ketoconazole, it may slow down its metabolism and prolong its duration of action. This may lead to excessive drug efficacy or prolonged duration, increasing the risk of adverse reactions. Therefore, special attention should be paid to the patient's reaction during use and the medication plan should be adjusted in a timely manner.
Sulfonamide drugs
When used in combination with sulfonamide drugs such as sulfamethoxazole and sulfamethoxazole, the likelihood of allergic reactions may increase. Therefore, for patients allergic to sulfonamide drugs, this substance should be prohibited.
The frequency of monitoring blood pressure in elderly people after use should follow the following guidelines:
For patients with initial treatment stage or unstable blood pressure
During the initial treatment stage, unstable blood pressure, or adjustment of medication treatment plan, it is recommended to measure blood pressure every morning and evening (2-3 times each time, take the average), measure continuously for 7 days, and calculate the average blood pressure after 6 days
Long term medication treatment for patients
For elderly patients undergoing long-term medication treatment, it is recommended to monitor their blood pressure status before taking medication to evaluate the efficacy of the medication. It is best to self measure sitting blood pressure at a fixed time after waking up in the morning, taking antihypertensive medication, before breakfast, and after urination.
Follow up after antihypertensive drug treatment
After initiating new drugs or adjusting medication treatment, monthly follow-up evaluations are required to assess compliance and treatment response until the blood pressure is reduced to standard. The follow-up content includes the compliance of blood pressure values, whether there has been orthostatic hypotension, and whether there have been any adverse drug reactions.
Individuals with stable blood pressure control
For elderly patients with stable blood pressure control, the monitoring frequency can be reduced and blood pressure can be measured only one day a week.
Case 1: Surgical Anesthesia
Application Scenario:
Powdered bupivacaine hydrochloride is widely used in surgical procedures, especially when nerve block anesthesia, epidural anesthesia, and infiltration anesthesia are involved. Its anesthesia effect is rapid and reliable, and helps to reduce patients' pain and anxiety.
Application Procedure:
Doctors dissolve bupivacaine hydrochloride powder in a suitable solvent to make an injection or spray. The drug is applied to the nerves or tissues in the surgical area by injection or spray before surgery to achieve anesthesia.
Application Effect:
By using bupivacaine hydrochloride powder, doctors are able to successfully provide patients with local anesthesia for a smoother and safer surgical procedure. The patient felt significant pain relief during the procedure and the outcome of the surgery was guaranteed.
Case 2: Pain Management
Application Scenario:
Bupivacaine hydrochloride powder is also used as an effective therapeutic drug for patients with chronic pain, especially those who need long-term pain management.
Application process:
Doctors will develop an individualized treatment plan based on the patient's specific situation. Often, bupivacaine hydrochloride is made into dosage forms such as gels or creams, which patients can self-administer at home.
Application Effect:
By using bupivacaine hydrochloride gel or cream, patients are able to feel a significant reduction in pain and a significant improvement in their quality of life. At the same time, the drug also has a low risk of side effects, providing patients with a safe and effective pain management program.
Case 3: Pharmaceutical raw materials
Application Scenario:
Bupivacaine hydrochloride powder is also widely used as a pharmaceutical raw material for the manufacture of various bupivacaine preparations, such as injections, sprays, gels and creams.
Application Process:
Pharmaceutical companies will mix and process bupivacaine hydrochloride powder with other pharmaceutical ingredients to make various dosage forms of drugs. These drugs have a wide range of applications in the medical field, providing doctors with more treatment options.
Application Effect:
By using bupivacaine hydrochloride as a pharmaceutical raw material, pharmaceutical companies are able to produce a variety of dosage forms of drugs to meet the different therapeutic needs of doctors. At the same time, the efficacy of these drugs has been widely recognized, providing patients with better therapeutic effects and a more comfortable treatment experience.
Tetracaine HCl Powder has a wide range of applications and significant clinical value in the medical field. However, the drug also requires strict adherence to doctor's advice and instructions for use to ensure its safe and effective use.
As the economy and technology progresses, the market demands higher quality 99% Raw Benzocaine Lidocaine Procaine HCl Tetracaine Hydrochloride Local Anesthetic Powder, so the only way to meet the market demand is to keep improving technology. Creating and sharing is the guiding principle of our company to share the fruits of development with our employees. We take integrity, responsibility, innovation and aggressiveness as our talent values, and are committed to cultivating talent, introducing talent and using talent well.